tert-Butyl 2-(2-(tert-butylthio)pyridin-3-yl)piperidine-1-carboxylate

Catalog No. :
ACMTVE978
CAS No. :
1352497-13-2
Molecular Formula :
C19H30N2O2S
Molecular Weight :
350.53

IUPAC Name:tert-butyl 2-(2-(tert-butylthio)pyridin-3-yl)piperidine-1-carboxylate

tert-Butyl 2-(2-(tert-butylthio)pyridin-3-yl)piperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$986.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 2-(2-(tert-butylthio)pyridin-3-yl)piperidine-1-carboxylate
IUPAC Nametert-butyl 2-(2-(tert-butylthio)pyridin-3-yl)piperidine-1-carboxylate
MDL No.MFCD20533354
Molecular FormulaC19H30N2O2S
Molecular Weight350.53
SMILESO=C(N1CCCCC1C2=CC=CN=C2SC(C)(C)C)OC(C)(C)C
InChI KeyIYYSJPJTUJKIOI-UHFFFAOYSA-N
Synonym2-tert-Butylsulfanyl-3,4,5,6-tetrahydro-2H-[2,3]bipyridinyl-1-carboxylic acid tert-butyl ester;1-Piperidinecarboxylic acid, 2-[2-[(1,1-dimethylethyl)thio]-3-pyridinyl]-, 1,1-dimethylethyl ester
CAS No.1352497-13-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACMTVE978 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAIRU561 route compound structure diagram
    ACAIRU56129364-29-2 In Stock
  4. Then
  5. ACMTVE978 route product structure diagram
    ACMTVE9781352497-13-2
Inquiry

2. ACMTVE978 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMTVE978 route product structure diagram
    ACMTVE9781352497-13-2
Inquiry

Comments (0)